Global /United States /Healthcare /Medical Devices /ENOV
chevron_leftBack

Enovis Corp.

ENOV
NYSE: ENOV Delayed
33.82USD 3.7%
As of 24 April 2025, Enovis Corp. has a market cap of $1.92B USD, ranking #5474 globally and #1468 in the United States. It ranks #501 in the Healthcare sector, and #52 in the Medical Devices industry.
Global Rank
5474
Country Rank
1468
Sector Rank
501
Industry Rank
52
Key Stats
Market Cap
$1.92BUSD
Enterprise Value
$3.28BUSD
Revenue (TTM)
$2.11BUSD
EBITDA (TTM)
$339.02MUSD
Net Income (TTM)
-$825.49MUSD
EBITDA Margin
16%
Profit Margin
-39%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Matthew Trerotola open_in_new
Employees
7,367
Founded
1995
IPO
08 May 2008
Website
enovis.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.7% 8.5% -13% -28% -16% -39%
Upcoming Earnings
Earnings Date
Thu, May 8
Earnings Time
sunny Before Open
EPS Estimate
$0.6600 32% yoy
Revenue Estimate
$544.71M 5.5% yoy

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
ENOV
Enovis Corp
ISIN: US1940145022
Shares Out.:
57.108M1 Shares Float: 56.106M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
33.82 USD
London Stock Exchange
MIC: XLON
0I1B
Enovis Corp
ISIN: US1940145022
Shares Out.:
57.108M1 Shares Float: 56.106M2
TV:
SA:
YF:
GF:
BA:
MS:
31.84 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Enovis Corp.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
Abbott Laboratories
ABT
$225.18B
12K%
Boston Scientific Corp.
BSX
$146.31B
8K%
Stryker Corp.
SYK
$136.3B
7K%
Edwards Lifesciences Corp.
EW
$41.27B
2K%
DexCom, Inc.
DXCM
$26.22B
1K%
Industry: Medical Devices (Global)
Name
Market Cap diff.
Medtronic plc
MDT
$107.41B
5K%
Siemens Healthineers AG
SHL
$57.76B
50.97B EUR
3K%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
$36.05B
262.7B CNY
2K%
Koninklijke Philips N.V.
PHIA
$22.27B
19.57B EUR
1K%
STERIS plc
STE
$22.0B
1K%